Plasma miRNA-122-5p and miRNA-151a-3p identified as potential biomarkers for liver injury among CHB patients with PNALT

被引:28
作者
Cheng, Jin-Lin [1 ]
Zhao, Hong [2 ]
Yang, Shi-Gui [1 ]
Chen, Er-Mei [1 ]
Chen, Wen-Qian [1 ]
Li, Lan-Juan [1 ]
机构
[1] Zhejiang Univ, State Key Lab Diag & Treatment Infect Dis, Collaborat Innovat Ctr Diag & Treatment Infect Di, Affiliated Hosp 1,Sch Med, 79 Qingchun Rd, Hangzhou 310003, Zhejiang, Peoples R China
[2] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China
基金
中国国家自然科学基金;
关键词
Hepatitis B virus; Normal ALT; MicroRNA; Biomarker; CHRONIC HEPATITIS-B; ALANINE AMINOTRANSFERASE; CIRCULATING MICRORNAS; VIRUS-INFECTION; SERUM; EXPRESSION; PREDICTION; DISEASES; CANCER;
D O I
10.1007/s12072-018-9871-0
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Plasma microRNA (miRNA) levels may be altered during pathological processes; therefore, they may potentially serve as biomarkers for the diagnosis and prognosis of human diseases. This study aimed to explore whether plasma miRNAs may serve as new biomarkers for liver injury among chronic hepatitis B (CHB) patients with normal or nearly normal alanine aminotransferase (ALT) levels. Plasma miRNAs from each of three independent groups (no prominent liver injury and persistently normal ALT levels, NPNALT; significant liver injury with persistently normal ALT levels, SPNALT; and healthy) were profiled by miRNA microarray analysis. Differentially expressed miRNAs were then validated by a quantitative reverse transcription polymerase chain reaction (qRT-PCR) assay. The area under the receiver operating characteristic (AUC) curve was used to analyze the candidate miRNAs validated by qRT-PCR for diagnostic accuracy. Twenty differentially expressed miRNAs were identified by microarray analysis. Seven miRNAs with elevated serum levels were validated by qRT-PCR analysis, and four of them were significantly different between the SPNALT and NPNALT groups. The AUCs of hsa-miR-122-5p and hsa-miR-151-3p were 0.877 (cutoff value = 13.38; 95% CI 0.792-0.963; sensitivity = 83.3%, specificity = 80%) and 0.882 (cutoff value = 7.4; 95% CI 0.797-0.966; sensitivity = 83.3%, specificity = 73.3%), respectively, indicating early liver injury. However, there was no significant correlation of miRNAs with either necroinflammation or fibrosis. Serum hsa-miR-122-5p and hsa-miR-151-3p may function as new biomarkers for liver injury in SPNALT patients. With these two biomarkers, we may be able to identify a subset of patients who are experiencing liver injury but have normal ALT levels for further evaluation with a biopsy procedure.
引用
收藏
页码:277 / 287
页数:11
相关论文
共 31 条
[1]   Circulating microRNA-22 correlates with microRNA-122 and represents viral replication and liver injury in patients with chronic hepatitis B [J].
Arataki, Keiko ;
Hayes, C. Nelson ;
Akamatsu, Sakura ;
Akiyama, Rie ;
Abe, Hiromi ;
Tsuge, Masataka ;
Miki, Daiki ;
Ochi, Hidenori ;
Hiraga, Nobuhiko ;
Imamura, Michio ;
Takahashi, Shoichi ;
Aikata, Hiroshi ;
Kawaoka, Tomokazu ;
Kawakami, Hiroiku ;
Ohishi, Waka ;
Chayama, Kazuaki .
JOURNAL OF MEDICAL VIROLOGY, 2013, 85 (05) :789-798
[2]   Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced, and inflammatory liver diseases [J].
Bala, Shashi ;
Petrasek, Jan ;
Mundkur, Shiv ;
Catalano, Donna ;
Levin, Ivan ;
Ward, Jeanine ;
Alao, Hawau ;
Kodys, Karen ;
Szabo, Gyongyi .
HEPATOLOGY, 2012, 56 (05) :1946-1957
[3]   Pathogenesis of hepatitis B virus infection [J].
Baumert, Thomas F. ;
Thimme, Robert ;
von Weizsaecker, Fritz .
WORLD JOURNAL OF GASTROENTEROLOGY, 2007, 13 (01) :82-90
[4]   microRNA-122 as a regulator of mitochondrial metabolic gene network in hepatocellular carcinoma [J].
Burchard, Julja ;
Zhang, Chunsheng ;
Liu, Angela M. ;
Poon, Ronnie T. P. ;
Lee, Nikki P. Y. ;
Wong, Kwong-Fai ;
Sham, Pak C. ;
Lam, Brian Y. ;
Ferguson, Mark D. ;
Tokiwa, George ;
Smith, Ryan ;
Leeson, Brendan ;
Beard, Rebecca ;
Lamb, John R. ;
Lim, Lee ;
Mao, Mao ;
Dai, Hongyue ;
Luk, John M. .
MOLECULAR SYSTEMS BIOLOGY, 2010, 6
[5]   Circulating MicroRNAs in Patients with Chronic Hepatitis C and Non-Alcoholic Fatty Liver Disease [J].
Cermelli, Silvia ;
Ruggieri, Anna ;
Marrero, Jorge A. ;
Ioannou, George N. ;
Beretta, Laura .
PLOS ONE, 2011, 6 (08)
[6]   Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases [J].
Chen, Xi ;
Ba, Yi ;
Ma, Lijia ;
Cai, Xing ;
Yin, Yuan ;
Wang, Kehui ;
Guo, Jigang ;
Zhang, Yujing ;
Chen, Jiangning ;
Guo, Xing ;
Li, Qibin ;
Li, Xiaoying ;
Wang, Wenjing ;
Zhang, Yan ;
Wang, Jin ;
Jiang, Xueyuan ;
Xiang, Yang ;
Xu, Chen ;
Zheng, Pingping ;
Zhang, Juanbin ;
Li, Ruiqiang ;
Zhang, Hongjie ;
Shang, Xiaobin ;
Gong, Ting ;
Ning, Guang ;
Wang, Jun ;
Zen, Ke ;
Zhang, Junfeng ;
Zhang, Chen-Yu .
CELL RESEARCH, 2008, 18 (10) :997-1006
[7]   Circulating MicroRNAs Novel Biomarkers and Extracellular Communicators in Cardiovascular Disease? [J].
Creemers, Esther E. ;
Tijsen, Anke J. ;
Pinto, Yigal M. .
CIRCULATION RESEARCH, 2012, 110 (03) :483-495
[8]   The next thing in prognostic molecular markers: microRNA signatures of cancer [J].
Grady, William M. ;
Tewari, Muneesh .
GUT, 2010, 59 (06) :706-708
[9]   miRTarBase update 2014: an information resource for experimentally validated miRNA-target interactions [J].
Hsu, Sheng-Da ;
Tseng, Yu-Ting ;
Shrestha, Sirjana ;
Lin, Yu-Ling ;
Khaleel, Anas ;
Chou, Chih-Hung ;
Chu, Chao-Fang ;
Huang, Hsi-Yuan ;
Lin, Ching-Min ;
Ho, Shu-Yi ;
Jian, Ting-Yan ;
Lin, Feng-Mao ;
Chang, Tzu-Hao ;
Weng, Shun-Long ;
Liao, Kuang-Wen ;
Liao, I-En ;
Liu, Chun-Chi ;
Huang, Hsien-Da .
NUCLEIC ACIDS RESEARCH, 2014, 42 (D1) :D78-D85
[10]   MicroRNA control of signal transduction [J].
Inui, Masafumi ;
Martello, Graziano ;
Piccolo, Stefano .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2010, 11 (04) :252-263